New Drug Application of Paclitaxel: Results Discussion

New medicine Application of Paclitaxel Results DiscussionThe present research work is an attempt made to design and development of a new do medicates application for of Paclitaxel continue rick microspheres by using bonce Gelation and declaration vapour methods is to achieve first arrangement to improve bioavailability and reduce side effects of paclitaxel. For this purpose different polymers equal HPMC K100, EUDRAGIT RS100, ETHYL CELLULOSE, and in combination were used. Based on the above investigational reports. I concluded the following results and discussions.7.1. Pre readiness StudiesThe reports repoint the exhibit frank and passable guide properties. So there is no need to improve the give ear of the powder. The regression value obtained from analytical method development in buffer media is 0.999.so, the medicate is exhibiting linearity in concentration 2ug to 10 ug.The FT-IR spectral studies indicate good stability and no chemical interaction among the do medicatess and excipients used.7.1.1. Identification of paclitaxelIn identification of API it was order that paclitaxel was dissoluble in methanol, ethanol, acetone7.2 Stability studies7.2.1. Photo stabilityWhen paclitaxel was exposed to light for a period of 2 months (60days) it was found that 0.2% of the drug was degraded.7.2.2. Acidic degradationWhen the drug was exposed in acidic medium 0.1N HCL for a period of 24 hrs , it was found that there is no degradation of the drug in alkaline mediums showing 100% stability in the acidic medium.7.2.3. basic degradationWhen the drug was exposed in different alkaline mediums like phosphate buffer 7.4 for a period of 24 hrs, it was found that there is no degradation of the drug in alkaline mediums showing 100% stability in alkaline medium.7.2.4 Temperature stress conditionsWhen the drug was exposed to different temperatures (00C, 100C, 200C, 300C, 350C, 450C and 500C, 600C) for a clock time period of 1hr, 3hr, 6hr, 12hr, 24hr, was fo und that there is no degradation of the drug in Temperature stress conditions.7. 3.Solubility studiesSolubility of paclitaxelPaclitaxel is soluble in methanol, ethanol, acetone etc.paclitaxel is in soluble in waterMelting PointIt was also found Melting point of paclitaxel was 2160c,DensityOn analyzing for density it was found that paclitaxel showed bulk density value 0.593gm/ml and tapped density value 0.514 gm/ml,Carrs IndexThe value of Carrs Index for 13.32 and drugs showed good flow feature articlesCompressibility IndexThe value of Compressibility Index for was 14.28, and drugs showed good characteristics.Hausners ratioThe value of Hausners ratio for paclitaxel was 1.16 drugs showed good flow characteristics.Angle of ReposeThe studies on angle of repose showed that was 26.83 values indicated good flow properties.Stability studiesFTIR studiesFrom the FTIR spectra, it was concluded that similar characteristic peaks with minor difference for the drug and their verbal expression. H ence, it appears that there was no chemical interaction between the drugs and excipients used. The IR Spectra of paclitaxel with HPMC K100, Eudragit Rs100, Ethyl cellulose were shown in figs. The following peaks were observed in as well as paclitaxel with excipients.EVALUATION OF MICROSPHERESDetermination of division yieldThe percentage yield was estimated from all the 18 trainings the results obtained between the range 86.03 %to 76.56%.all the formulation was found within the limits.Drug entrapment efficiencyThe drug entrapment of all formulation of paclitaxel microspheres varied from 86.19 to 67.38Particle size analysisThe particle size of the microspheres of the paclitaxel formulations varied from 836 m to 191m.In vitro drug melt studies The formulation F1, F4, F7 contains HPMC K 100,Eudragit Rs100, Ethyl cellulose, as a polymers in 1% concentration lively by ionic gelation method. These formulations subjected to drug release studies in 7.4 ph phosphate buffer as a licentio usness medium.The formulation F1 that containing 1% HPMC K100, occur of the drug is release 36.92% in 48 hrs. . And the formulation F4 containing 1% Eudragit Rs 100, add of the drug release 43.92 in 48hrs, The formulation F7 containing 1 % Ethyl cellulose , amount of the drug release 68.96 in 48hrs.The formulation F2 that containing 20mg HPMC k 100, 10mg, Eudragit Rs 100, amount of drug is release 41.73 in 48hr. the formulation F3containing 10mg Ethyl cellulose, 20mg HPMC K 100, amount of drug release 46.98 in 48 hrs.the formulation F5 containing 20mg Eudragit Rs100, 10mgHPMC K 100 amount of drug release 50.24 in 48 hrs. the formulation F6 containing 20mg Eudragit, 10mgEthyl cellulose amount of drug release53.28 in 48hrs. The formulation F8 that containing 10mg HPMC k 100, 20mgEthyl cellulose, amount of drug is release 63.24 in 48hrs, the formulation F9containing 20mgEthyl cellulose, 10mg Ethyl cellulose, amount of drug release 56.23 in 48 hrs.From formulations F1 to F9 shows cumu lative percentage drug release in 48 hr in between 36.92% to 68.96%.The formulation F10, F13, F16 contains HPMC K 100,Eudragit Rs100, Ethyl cellulose, as a polymers in 1% concentration prep ared by solvent evaporation method. These formulations subjected to drug release studies in 7.4 ph phosphate buffer as a dissolution medium.The formulation F10 that containing 1% HPMC K100, amount of the drug is release 42.28% in 48 hrs. . And the formulation F13 containing 1% Eudragit Rs 100, amount of the drug release 49.32 in 48hrs, The formulation F16 containing 1 % Ethyl cellulose , amount of the drug release 79.42in 48hrs.The formulation F11 that containing 20mg HPMC k 100, 10mg, Eudragit Rs 100, amount of drug is release 46.43 in 48hr. the formulation F12containing 10mg Ethyl cellulose, 20mgHPMC K 100, amount of drug release 53.67 in 48 hrs. The formulation F14 containing 20mg Eudragit Rs100, 10mgHPMC K 100 amount of drug release 55.86 in 48 hrs. the formulation F15 containing 20mg Eudragi t, 10mgEthyl cellulose amount of drug release59.11 in 48hrs. The formulation F17 that containing 10mg HPMC k 100, 20mgEthyl cellulose, amount of drug is release 74.82 in 48hrs. the formulation F18containing 20mgEthyl cellulose, 10mg Ethyl cellulose, amount of drug release 65.24 in 48 hrs.From formulations F10 to F18 shows cumulative percentage drug release in 48 hr in between 42.28% to 79.42%.The release profiles showed a characteristic initial burst release followed by a lag period and further initiation of sustained release. After the initial lag, a nearly linear and continuous release was observed over 48 hr Comparison of in-vitro drug release profiles for all formulations F1to F9 and F10 to F18 are shown in Fig (7,8) and the data is shown in Tables (13,14). solution of method of preparationIonic gelationsolvent evaporation1. On particle size From formulations F1to F9 are by ionic gelation method.Spheres obtained are larger than desired particle size range i.e 609-875.m.formulat ions F10 to F18 are by solvent evaporation, are in desired particle size range i.e191-303 m.So that Spheres obtained are smaller than by ionic gelation method.2. On Drug releaseDrug release is sustained in formulations fain by solvent evaporation than with ionic gelation.Therefore from above results solvent evaporation method is selected.Effect of polymersHPMC K100, Ethyl cellulose,Eudragit RS100 are three different polymers used as sustained release polymers.Formulations F1,F4,F7 by ionic gelation where as F10,F13,F16, by solvent evaporation are with single polymer respectively.Remaining all formulations are combination of two each polymers of respective ratiosHPMC K100 is hydrophilic,Ethyl cellulose is hydrophobic nature.Combination of Hydrophilic and Hydrophobic polymers is time-tested at different ratios to finalise effect on sustained drug releaseAlso HPMC K100 with coating polymer Eudragit RS 100 combination is tested at different ratiosAmong all these ,F10 i.e,with single polymer HPMC K100 by solvent evaporation method shows desired drug release compared to combination of polymers.Therefore it is concluded that there is no effect of combination of polymers on drug release of paclitaxel microspheres.Kinetics of drug release from optimized formulationThe kinetics of the drug release was evaluated by drug release rate models namely zero order, First order. The mechanisms of drug release was evaluated by First order drug release. The dissolution kinetics data was defected in table 15 and the comparative dissolution profile was given in the figure 9 .The drug release followed zero order kinetics in all polymers employed. The graph drawn in between time Vs cumulative % drug release show in figure 12 to 15.